![Tadashi Matsumoto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tadashi Matsumoto
Fondatore presso ReqMed Co., Ltd.
Posizioni attive di Tadashi Matsumoto
Società | Posizione | Inizio | Fine |
---|---|---|---|
ReqMed Co., Ltd.
![]() ReqMed Co., Ltd. Pharmaceuticals: MajorHealth Technology ReqMed Co., Ltd. engages in drug development and consulting services. Its projects include development of pentosan polysulfate which alleviate pain symptoms of osteoarthritis, and eltoprazine which are used in the diseases such as attention-deficit hyperactivity disorder, cognitive impairment associated with schizophrenia and dyskinesia associated with Parkinson disease. The firm's clients include pharmaceutical and bio-pharmaceutical companies. The company was founded by Tadashi Matsumoto on May 12, 1998 and is headquartered in Machida, Japan. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
Fondatore | 12/05/1998 | - | |
Presidente | 12/05/1998 | - | |
Kihara Memorial Yokohama Foundation For The Advancement | Direttore/Membro del Consiglio | 01/01/2010 | - |
Japan Ministry of Economy, Trade & Industry | Corporate Officer/Principal | 01/01/2009 | - |
Storia della carriera di Tadashi Matsumoto
Precedenti posizioni note di Tadashi Matsumoto
Società | Posizione | Inizio | Fine |
---|---|---|---|
TELLA, INC. | Direttore/Membro del Consiglio | 01/03/2017 | 27/03/2019 |
ReqMed Research, Inc. | Amministratore Delegato | 01/01/1999 | - |
Formazione di Tadashi Matsumoto
University of Tokyo | Undergraduate Degree |
University of Tsukuba | Masters Business Admin |
Statistiche
Distribuzione geografica
Giappone | 7 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Founder | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Government | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Japan Ministry of Economy, Trade & Industry | Government |
ReqMed Co., Ltd.
![]() ReqMed Co., Ltd. Pharmaceuticals: MajorHealth Technology ReqMed Co., Ltd. engages in drug development and consulting services. Its projects include development of pentosan polysulfate which alleviate pain symptoms of osteoarthritis, and eltoprazine which are used in the diseases such as attention-deficit hyperactivity disorder, cognitive impairment associated with schizophrenia and dyskinesia associated with Parkinson disease. The firm's clients include pharmaceutical and bio-pharmaceutical companies. The company was founded by Tadashi Matsumoto on May 12, 1998 and is headquartered in Machida, Japan. | Health Technology |
ReqMed Research, Inc. | |
Kihara Memorial Yokohama Foundation For The Advancement | |
tella, Inc.
![]() tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Tadashi Matsumoto
- Esperienza